Truist Financial Has Lowered Expectations for The Cigna Group (NYSE:CI) Stock Price

The Cigna Group (NYSE:CI - Get Free Report) had its price objective dropped by analysts at Truist Financial from $390.00 to $375.00 in a research note issued on Tuesday,Benzinga reports. The brokerage presently has a "buy" rating on the health services provider's stock. Truist Financial's price target indicates a potential upside of 30.81% from the stock's current price.

A number of other research analysts also recently commented on the company. Stephens lowered their price objective on The Cigna Group from $410.00 to $380.00 and set an "overweight" rating for the company in a research note on Friday, January 31st. Wells Fargo & Company lowered their price target on shares of The Cigna Group from $370.00 to $341.00 and set an "equal weight" rating for the company in a research report on Tuesday. Deutsche Bank Aktiengesellschaft decreased their target price on shares of The Cigna Group from $398.00 to $394.00 and set a "buy" rating for the company in a research report on Monday, November 4th. Oppenheimer cut their price objective on shares of The Cigna Group from $400.00 to $375.00 and set an "outperform" rating on the stock in a research note on Friday, January 31st. Finally, Royal Bank of Canada reduced their price objective on shares of The Cigna Group from $384.00 to $377.00 and set an "outperform" rating for the company in a report on Friday, November 1st. Three analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $373.69.

The Cigna Group Stock Down 0.2 %

NYSE CI traded down $0.56 during trading hours on Tuesday, reaching $286.67. 1,271,358 shares of the company traded hands, compared to its average volume of 1,837,462. The stock has a market capitalization of $79.74 billion, a PE ratio of 23.42, a PEG ratio of 0.97 and a beta of 0.54. The company has a current ratio of 0.66, a quick ratio of 0.72 and a debt-to-equity ratio of 0.70. The Cigna Group has a 12 month low of $262.03 and a 12 month high of $370.83. The company has a 50 day moving average of $290.87 and a two-hundred day moving average of $323.07.

The Cigna Group (NYSE:CI - Get Free Report) last released its earnings results on Thursday, January 30th. The health services provider reported $6.64 EPS for the quarter, missing analysts' consensus estimates of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same period in the prior year, the company posted $6.79 EPS. As a group, equities analysts expect that The Cigna Group will post 29.66 earnings per share for the current year.

Hedge Funds Weigh In On The Cigna Group

Institutional investors have recently bought and sold shares of the stock. Collier Financial acquired a new position in The Cigna Group in the 4th quarter valued at $32,000. ORG Wealth Partners LLC acquired a new position in shares of The Cigna Group during the 4th quarter worth about $34,000. Ulland Investment Advisors LLC boosted its stake in The Cigna Group by 2,500.0% during the 3rd quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider's stock valued at $36,000 after purchasing an additional 100 shares during the period. Prospera Private Wealth LLC bought a new position in The Cigna Group in the 3rd quarter worth approximately $37,000. Finally, Compagnie Lombard Odier SCmA bought a new stake in shares of The Cigna Group in the fourth quarter valued at approximately $37,000. 86.99% of the stock is currently owned by institutional investors.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.